HT
UTHR icon

HAP Trading’s United Therapeutics UTHR Stock Holding History

HAP Trading’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$412K Buy
+25,000
New +$8.41M 0.03% 287
2017
Q4 		– Sell
-180,600
Closed -$12K – 1178
2017
Q3 		$12K Buy
+180,600
New +$23.1M ﹤0.01% 792

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

HAP Trading's UTHR Position: Q3 2017 in Review

HAP Trading sold out of United Therapeutics (UTHR) in Q3 2017, closing a stake of 11,702 shares — an estimated $1.49M sold.

HAP Trading first reported a position in UTHR in Q2 2017 and held it in 1 quarter. The position peaked at $1.52M in Q2 2017. 373 funds tracked by Wall St. Rank hold UTHR as of Q3 2017.

  • HAP Trading reported no remaining United Therapeutics position as of Q3 2017 after selling out during the quarter.
  • HAP Trading sold 11,702 United Therapeutics shares in Q3 2017, an estimated $1.49M.
  • HAP Trading first reported a position in United Therapeutics in Q2 2017 and held it in 1 quarter.
  • HAP Trading's United Therapeutics position peaked at $1.52M in Q2 2017.
  • 373 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2017.

Based on HAP Trading's 13F filing for Q3 2017, filed 8 Nov 2017.